Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Similars in SciELO
Share
Revista Científica Ciencia Médica
Print version ISSN 2077-3323On-line version ISSN 2220-2234
Abstract
GARAY QUIROGA, Jhemel and VALDEZ CARRIZO, Edgar. HEPATITIS B AND C IN PEOPLE WITH HIV FROM THE INSTITUTE FOR HUMAN DEVELOPMENT. Rev Cient Cienc Méd [online]. 2021, vol.24, n.1, pp.8-12. Epub July 01, 2021. ISSN 2077-3323. https://doi.org/10.51581/rccm.v24i1.337.
Introduction:
HIV co-infection with hepatitis B or C is the cause of chronic liver disease, with various seropre- valences in different regions of the world.
Objective:
To know the seroprevalence of hepatitis B and C in people with HIV who come for consultation at the Institute for Human Development, Cochabamba-Bolivia, management 2017-2018.
Materials and methods:
Descriptive, prospective-cross-sectional, quantitative, non-experimental study. The serological results of the markers were analyzed: Hepatitis B virus surface antigen, Hepatitis B virus anti-core antibody, Hepatitis C virus antibody; Hepatitis B vaccine history and antiretroviral treatment scheme of 195 people with HIV at the Institute for Human Development, bivariate analysis was performed to obtain data.
Results:
The seroprevalence obtained for hepatitis B is 7.7% and hepatitis C 0.5%; coinfection between HIV and hepatitis B is 80% with the antiretroviral regimen tenofovir / lamivudine. The homosexual population group has a 5.5 times risk of having HIV and hepatitis B co-infection with a p value of 0.006; Regarding immunization for hepatitis B, only 9.2% of patients have the complete scheme.
Conclusion:
It is imperative to offer hepatitis B and C testing to all people with HIV; emphasizing the most vulnerable groups (homosexuals); The provision of doses for complete immunization against hepatitis B in all public health services in the country is important.
Keywords : HIV; hepatitis B; hepatitis C; tenofovir; lamivudina.